Literature DB >> 25546194

13N-ammonia combined with 18F-FDG could discriminate between necrotic high-grade gliomas and brain abscess.

Xinchong Shi1, Chang Yi, Xiaoyan Wang, Bing Zhang, Zhifeng Chen, Ganghua Tang, Xiangsong Zhang.   

Abstract

PURPOSE: Accurate prediction of brain abscess is beneficial for timely management. In this study, we investigated the utility of 13N-ammonia and its combination with 18F-FDG in differentiating brain abscess from necrotic high-grade gliomas. PATIENTS AND METHODS: Thirteen patients with ring-like enhancement high-grade gliomas and 11 patients with brain abscess were recruited in our study. All of them underwent both 18F-FDG and 13N-ammonia PET imaging. Lesion uptake was evaluated by lesion to normal gray matter ratio (L/N). Histopathology diagnosis was obtained for all the patients after PET imaging.
RESULTS: The L/N values of 18F-FDG were not significantly different between brain abscess and necrotic high-grade gliomas (P = 0.35). The uptake of 13N-ammonia in gliomas was higher than that in abscess lesions (L/N: 1.38 ± 0.31 vs 0.84 ± 0.18, P < 0.001). The receiver operating characteristic curve analysis determined the optimal L/N cutoff value (13N-ammonia) of 1.0 with the area under the curve of 0.94 and the overall accuracy of 87.5%. Discriminant analysis demonstrated that the combination of 18F-FDG and 13N-ammonia could distinguish the 2 clinical entities with higher accuracy of 95%, and only 1 necrotic glioma lesion was misclassified into the abscess group.
CONCLUSIONS: 13N-ammonia is effective in distinguishing brain abscess from necrotic high-grade gliomas, and its combination with 18F-FDG could further elevate the diagnostic accuracy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25546194     DOI: 10.1097/RLU.0000000000000649

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

Review 1.  13N-NH3 PET/CT in oncological disease.

Authors:  Domenico Albano; Raffaele Giubbini; Francesco Bertagna
Journal:  Jpn J Radiol       Date:  2019-10-10       Impact factor: 2.374

Review 2.  Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.

Authors:  Francesco Ceci; Andrei Iagaru; R Laudicella; N Quartuccio; G Argiroffi; P Alongi; L Baratto; E Califaretti; V Frantellizzi; G De Vincentis; A Del Sole; L Evangelista; S Baldari; S Bisdas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-13       Impact factor: 10.057

3.  Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by 18F-FDG and 13N-Ammonia PET/CT.

Authors:  Lei Ding; Fangling Zhang; Qiao He; Zhoulei Li; Xinchong Shi; Ruocheng Li; Xiangsong Zhang
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

4.  Pharmacological Vitamin C Treatment Impedes the Growth of Endogenous Glutamine-Dependent Cancers by Targeting Glutamine Synthetase.

Authors:  Yali Long; Jia Qiu; Bing Zhang; Peng He; Xinchong Shi; Qiao He; Zhifeng Chen; Wanqing Shen; Zhoulei Li; Xiangsong Zhang
Journal:  Front Pharmacol       Date:  2021-05-11       Impact factor: 5.810

5.  Identify glioma recurrence and treatment effects with triple-tracer PET/CT.

Authors:  Cong Li; Chang Yi; Yingshen Chen; Shaoyan Xi; Chengcheng Guo; Qunying Yang; Jian Wang; Ke Sai; Ji Zhang; Chao Ke; Fanfan Chen; Yanchun Lv; Xiangsong Zhang; Zhongping Chen
Journal:  BMC Med Imaging       Date:  2021-05-31       Impact factor: 1.930

Review 6.  Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas.

Authors:  Filipa Martins; Luís G Gonçalves; Marta Pojo; Jacinta Serpa
Journal:  Biomolecules       Date:  2020-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.